What is Stoke Therapeutics, Inc.'s shares (basic)?

Stoke Therapeutics, Inc. (STOK) reported shares (basic) of 63.1M in Q1 2026.

How has Stoke Therapeutics, Inc.'s shares (basic) changed year-over-year?

Stoke Therapeutics, Inc.'s shares (basic) increased by 9.0% year-over-year, from 57.9M to 63.1M.

What is the long-term trend for Stoke Therapeutics, Inc.'s shares (basic)?

Over 3 years (2022 to 2025), Stoke Therapeutics, Inc.'s shares (basic) has grown at a 14.7% compound annual growth rate (CAGR), from 155M to 234M.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

Stoke Therapeutics, Inc. STOK Shares (Basic)

Shares (Basic) at other companies

Ionis PharmaceuticalsIONS

164.9M+3.9%

Jazz PharmaceuticalsJAZZ

61.9M+1.5%

Xenon PharmaceuticalsXENE

87.3M+11.0%

Praxis Precision Medicines, Inc.PRAX

28.9M+37.2%

Harmony Biosciences Holdings, Inc.HRMY

57.8M+0.9%

Nurix Therapeutics, Inc.NRIX

110.1M+31.7%

Other financials

Income statement

See full

Revenue$6.2M-96.1%

Operating income-$53.4M-148%

Net income-$50.0M-144%

EPS (diluted)-$0.79-142%

Balance sheet

See full

Cash & equivalents$155.7M-43.4%

Total debt$3.4M-42.5%

Total equity$394.9M+12.8%

Total assets$443.3M+8.9%

Cash flow

See full

Operating cash flow-$60.6M-146%

CapEx$353.0K+132%

Free cash flow-$60.9M-146%

Valuation

See full

Market cap$1.94B+436%

Enterprise value$1.79B+1,855%

P/S60.4×+58.5×

Profitability

See full

Operating margin-577.5%-597pp

Net margin-529.2%-556pp

FCF margin36.2%+18.4pp

Returns & leverage

See full

Return on equity-45.6%-66.1pp

Debt / equity0×0.0×

Current ratio9×+0.6×

Where this comes from

Reported directly by Stoke Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stoke Therapeutics, Inc.'s shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Stoke Therapeutics, Inc.'s shares (basic)?: Stoke Therapeutics, Inc. (STOK) reported shares (basic) of 63.1M in Q1 2026.
How has Stoke Therapeutics, Inc.'s shares (basic) changed year-over-year?: Stoke Therapeutics, Inc.'s shares (basic) increased by 9.0% year-over-year, from 57.9M to 63.1M.
What is the long-term trend for Stoke Therapeutics, Inc.'s shares (basic)?: Over 3 years (2022 to 2025), Stoke Therapeutics, Inc.'s shares (basic) has grown at a 14.7% compound annual growth rate (CAGR), from 155M to 234M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.